Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-17

Clinical Trial Update: A Study of Oxytocin in Children and Adolescents With Autistic Disorder [Phase 2]

View source ↗

Summary

The document is a Phase 2 clinical trial update of oxytocin in children and adolescents with autism. Results from the study were posted in July 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Autism | Phase 2 | Status: COMPLETED | Results posted: 2017-07-17